Weekly Movers

Aldeyra Therapeutics Soars on Clinical Trial Results

September 29th, 2017

On September 12, Aldeyra Therapeutics reported positive results from its clinical trial of a treatment for dry eye disease. The company plans to continue its phase 2 clinical trials in early 2018. The news triggered a Sonal level 2 alert at 7:00 am...

Read More

Alnylam Pharmaceuticals Reports Clinical Trial Success

September 29th, 2017

On September 20, Alnylam Pharmaceuticals (ALNY) reported exciting stage 3 clinical trial results. Its drug, patisiran, treats a rare nerve disorder called familial amyloid polyneuropathy. Alnylam will seek regulatory approval for patisiran later...

Read More

AECOM Reveals Stock Repurchase Program

September 29th, 2017

After the close of the markets on September 21, AECOM (ACM) unveiled a new capital allocation policy and stock repurchase program. AECOM is a global infrastructure firm that plans to spend all available free cash flow to pay down debt until reaching...

Read More

QUAD Lands $450 Million Contract

September 28th, 2017

On September 20, Quad Graphics reported that it landed a $450 million printing contract. The Minnesota-based company will print all catalogs for the online retailer and fellow Minnesotans, Bluestem Brands, Inc.   The news triggered a level 3...

Read More

Interested in events that actually move the market?Awesome!

Let us send you a recap of every weeks market movers!

Better yet…Receive ALERTS
of Market Moving Events…
seconds after they surface!

  • Mergers & Acquisitions
  • Clinical Trials
  • Contract Awards
  • Stock Repurchase Programs
  • Earnings Announcement

Get Started